GIA
ELV icon

GHP Investment Advisors’s Elevance Health ELV Stock Holding History

GHP Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Buy
11,061
+5
+0% +$1.85K 0.16% 166
2026
Q1 		$3.24M Sell
11,056
-524
-5% -$172K 0.13% 181
2025
Q4 		$4.06M Sell
11,580
-771
-6% -$261K 0.17% 162
2025
Q3 		$3.99M Sell
12,351
-1,804
-13% -$561K 0.17% 161
2025
Q2 		$5.51M Buy
14,155
+853
+6% +$343K 0.24% 139
2025
Q1 		$5.79M Buy
13,302
+14
+0.1% +$5.62K 0.28% 134
2024
Q4 		$4.9M Sell
13,288
-1,300
-9% -$544K 0.23% 152
2024
Q3 		$7.59M Buy
14,588
+6
+0% +$3.21K 0.35% 109
2024
Q2 		$7.9M Buy
14,582
+79
+0.5% +$41.8K 0.39% 91
2024
Q1 		$7.52M Buy
14,503
+384
+3% +$191K 0.37% 98
2023
Q4 		$6.66M Buy
14,119
+375
+3% +$173K 0.36% 104
2023
Q3 		$6.24M Buy
13,744
+392
+3% +$178K 0.38% 97
2023
Q2 		$6.33M Buy
13,352
+1,203
+10% +$555K 0.37% 100
2023
Q1 		$5.59M Buy
12,149
+315
+3% +$150K 0.35% 102
2022
Q4 		$6.07M Buy
11,834
+666
+6% +$338K 0.41% 93
2022
Q3 		$5.07M Buy
11,168
+660
+6% +$316K 0.39% 97
2022
Q2 		$5.07M Buy
10,508
+586
+6% +$290K 0.38% 100
2022
Q1 		$4.87M Buy
9,922
+708
+8% +$324K 0.32% 115
2021
Q4 		$4.27M Buy
9,214
+1,128
+14% +$475K 0.3% 117
2021
Q3 		$3.01M Buy
8,086
+1,855
+30% +$705K 0.24% 138
2021
Q2 		$2.38M Buy
6,231
+2,341
+60% +$895K 0.19% 161
2021
Q1 		$1.4M Buy
3,890
+1,638
+73% +$527K 0.12% 180
2020
Q4 		$723K Buy
2,252
+776
+53% +$238K 0.07% 202
2020
Q3 		$396K Buy
1,476
+385
+35% +$104K 0.04% 232
2020
Q2 		$287K Buy
1,091
+19
+2% +$5.07K 0.04% 244
2020
Q1 		$243K Buy
1,072
+17
+2% +$4.63K 0.04% 259
2019
Q4 		$319K Hold
1,055
– – 0.03% 263
2019
Q3 		$253K Hold
1,055
– – 0.03% 277
2019
Q2 		$298K Hold
1,055
– – 0.04% 274
2019
Q1 		$303K Hold
1,055
– – 0.04% 272
2018
Q4 		$277K Hold
1,055
– – 0.04% 259
2018
Q3 		$289K Hold
1,055
– – 0.04% 264
2018
Q2 		$251K Hold
1,055
– – 0.04% 266
2018
Q1 		$232K Hold
1,055
– – 0.03% 272
2017
Q4 		$237K Sell
1,055
-105
-9% -$22.4K 0.03% 278
2017
Q3 		$220K Hold
1,160
– – 0.03% 278
2017
Q2 		$218K Buy
+1,160
New +$208K 0.03% 283

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

GHP Investment Advisors's ELV Position: Q2 2026 in Review

GHP Investment Advisors increased its Elevance Health (ELV) stake by 0.05% in Q2 2026, buying an estimated $1.85K and bringing the position to 11,061 shares worth $4.28M. The position accounts for 0.16% of the portfolio, ranked #166.

GHP Investment Advisors first reported a position in ELV in Q2 2017 and has held it in 37 quarters since. The position peaked at $7.9M in Q2 2024. 632 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • GHP Investment Advisors held 11,061 shares of Elevance Health worth $4.28M as of Q2 2026.
  • GHP Investment Advisors bought 5 Elevance Health shares in Q2 2026, an estimated $1.85K.
  • Elevance Health made up 0.16% of GHP Investment Advisors's portfolio in Q2 2026, its #166 holding.
  • GHP Investment Advisors first reported a position in Elevance Health in Q2 2017 and has held it in 37 quarters since.
  • GHP Investment Advisors's Elevance Health position peaked at $7.9M in Q2 2024.
  • 632 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.